Patients with chronic obstructive pulmonary disease (COPD) make up a large proportion of hospital in-patients; they account for 12% of general medical admissions. Decisions to ventilate a patient with an exacerbation of COPD are partly based on the physician's prediction of future quality of life. In this systematic review, Pubmed, Medline, Embase, Biomed Central and the Cochrane library were electronically searched for observational and interventional studies of healthrelated quality of life (HRQoL) in patients with COPD, who were invasively ventilated, survived to hospital discharge and were followed up for HRQoL measurements to be made. The results of the nine studies included showed that HRQoL does deteriorate after invasive ventilation in intensive care, but is similar to that of patients who are on long-term oxygen therapy (LTOT) or in pulmonary rehabilitation programmes. Despite the high long-term mortality of patients with COPD, the HRQoL in patients who do survive is reasonable. Identifying these patients remains a significant challenge.
Introduction
There is more to life than measuring death. The World Health Organization defined health as being not only the absence of disease and infirmity but also the presence of physical, mental and social well-being. 1 To understand the value of critical care we need to be able to measure long-term health as well as the immediate outcomes. Health and well-being are multifaceted. Each therapeutic intervention will affect an individual differently, but this effect needs to be measured by standardised, reliable and validated tests so that others can understand health-related quality of life (HRQoL). Health status encompasses measurement of physical, functional, emotional and mental wellbeing, whereas quality of life incorporates specific values and patient preferences including elements of work, friendships and family life.
Background
Chronic obstructive pulmonary disease (COPD) is characterised by progressive pulmonary airflow obstruction which may not be fully reversible and tends not to change rapidly over time. Airflow obstruction is defined as a ratio of forced expiratory flow in one second (FEV 1 ) to forced vital capacity (FVC) of less than 0.7. COPD is the third biggest cause of respiratory death and accounts for a fifth of respiratory mortality in the UK. Over 900,000 people in England and Wales have been diagnosed with COPD (to 2000). 2 One in eight emergency hospital admissions are due to COPD and it accounts for over one million bed-days per year in the UK. Wildman et al 3 reported that from 1995 to 2001 in the UK, COPD accounted for 2.9% of non-surgical admissions. In Canada, Wang et al reported that 26% of patients with an exacerbation of COPD were treated in an intensive care unit (ICU); 19.9% received mechanical ventilation, 87.5% of which was non-invasive ventilation (NIV). 4 The median length of stay in ICU in this study was six days. In the UK, the median ICU length of stay is four days and median hospital length of stay 16 days 3 .
Methods
The aim of this systematic review was to examine the HRQoL of those patients suffering from COPD who had been ventilated on ICU. The Cochrane strategy was used to search Medline, EMBASE, Biomed and the National Research register in October 2005. 5 Search terms were 'COPD OR ([{chronic obstructive} AND pulmonary OR airways OR lung] AND disease) OR COLD OR COAD AND (explosion of) ventilation AND critical OR intensive care'. Relevant studies were first identified by title and then abstract; all relevant studies were reviewed in full. No language or year of publication restrictions were applied. Bibliographies of relevant reviews were searched and further appropriate studies identified. The search incorporated studies that included patients with COPD who were invasively ventilated (as opposed to only NIV), survived to hospital discharge and had a HRQoL assessment at some point after discharge from ICU. Studies that only looked at predictors of mortality were excluded.
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Results Studies
Seven hundred and eighteen studies were identified by the search criteria. Twenty-two studies were identified by title and these abstracts searched. Twelve studies were searched in full text and included, while ten were excluded because they were reviews, or did not contain HRQoL measures. Eight studies were included after full review of the manuscript; the excluded reviews were searched for references 6 and one more study was identified from the reviews, making the final number of included studies nine (Figure 1 ).
Demographics
Of the nine studies identified, one was based in the UK, 7 one in Canada, 4 one in the USA 8 and the rest in Europe (Germany, 9 France, 10,11 Italy 12 and Spain 13, 14 ) . Five were single centre trials 7, 9, 11, 12, 14 and four were multicentre. 4, 8, 10, 13 All studies recruited patients between 1989 and 1999. One study (Wang et al 2005) did not give the enrolment period, only that it extended over twelve months. 4 Three were retrospective observational studies with prospective collection of quality of life measurement. 4, 7, 9 Five studies were prospective cohort studies 8, 10, 11, 13, 14 while one was a prospective controlled trial 12 ( Table 1) .
All studies included patients with COPD who had been admitted to intensive care and were ventilated. All the studies assessed HRQoL at varying times after ICU discharge. All studies excluded paediatric patients and one study excluded all patients less than 40 years old. 4 All studies reported age, sex, and length of stay on ICU, APACHE II or III scores and a measure of HRQoL.
Quality of life measurement
None of the studies measured HRQoL at the same time after ICU discharge. Hill et al did not quantify when HRQoL was measured. 7 The Euteneuer et al study reported HRQoL measurements from 37 patients less than six months following ICU discharge and 87 patients to whom the HRQoL measurements were administered more than six months after discharge. 9 
Individual study results
These are shown in Table 2 . Hill et al included 46 COPD patients of whom 21 survived hospital admission and 17 were followed up. This group did not use a validated HRQoL instrument; they asked the general practitioner about the patient' s dependence, exercise tolerance and quality of life (improved, worsened or stayed the same). Hill reported 49% hospital mortality and 59% one year mortality. Fifty-three percent of the survivors were dependent on carers and housebound. The questionnaire, which was completed by the general practitioner only, showed that 59% of survivors had a higher dependence on carers, a worse exercise tolerance and a poorer quality of life than before admission. 7 Euteneuer et al identified 403 patients, of whom 305 (76%) survived hospital admission and 124 (31% of admissions) survived to be followed up. Thirty-seven survived less than six months and 87 survived over six months. Of the questionnaires sent out, only 73 patients replied in full, of whom 37 were COPD patients who had been ventilated. This study used both SF-36 and SGRQ; it showed that the HRQoL in patients who receive invasive ventilation and survive is lower than both the reference normal population and the patients who had stable COPD and did not receive long-term oxygen therapy (LTOT) or invasive ventilation. The HRQoL was similar to COPD patients on NIV and LTOT. 15, 16 There were increased rates of depression and anxiety which play an important part in HRQoL. 9 Rivera-Fernandez et al identified 742 COPD patients, of Citations excluded n=664
• Not relevant whom 379 needed admission for an exacerbation of COPD and received invasive ventilation. They administered the QoL-Sp questionnaire pre-admission to ICU and six years later, as well as the GOS at discharge. The total group results included other COPD patients who were admitted for pneumonia (n=59), unscheduled surgery (n=29), scheduled surgery (n=24), postrespiratory arrest (n=33) and post-cardiac arrest (n=12). ICU mortality for the whole group was 23%, hospital mortality was 32% and at six year follow-up, 32% of patients who survived hospital had died. Of the surviving patients, 22% were lost to follow-up. The results of the GOS showed that 135 were normal, 315 were disabled but self-sufficient, 291 disabled and not self-sufficient and one was in a persistent vegetative state. One hundred and seven patients were alive and followed up.
Overall HRQoL score pre-admission was 4.92 (SD 4.5) points and deteriorated to 6.55 (SD 5.6) points after six years (p=0.009). No statistically significant relationship with age, APACHE III or length of stay in ICU was found, but there was a significant association with the Therapeutic Intervention Scoring System (TISS) (p=0.041). Of the patients admitted with exacerbation of COPD who required invasive ventilation, 27% died in the ICU, 37% died in the hospital and 31% had died at six years after hospital discharge. Nineteen percent could not be traced, which left 50 for follow-up. Their HRQoL had worsened but not statistically, 5.38 (SD 4.64) preadmission to 6.94 (SD 5.78) points, p=0.13. Of these patients, 72% were self-sufficient. Multiple regression analysis showed that HRQoL after admission was not related to pre-admission HRQoL, age or APACHE III score. 13 Wang et al 4 retrospectively enrolled 282 COPD patients. Of these patients, 241 (86%) survived hospital admission and were discharged home. One hundred and fifty-six patients were followed up and 85 were lost to follow-up. Of the patients followed up at two years, 70 patients had died but 84 (30% of admissions) were still alive. Only 54 completed the questionnaires. Of the 282 patients admitted to hospital with COPD, only 74 (26%) were admitted to intensive care and only 19% needed mechanical ventilation, mostly NIV; only seven needed intubation for invasive ventilation. The outcomes of the ventilated patients are not discussed in detail, but Wang does specify that among the patients who died or required long-term hospital stays, most had received intensive care treatment (84%) and mechanical ventilation (71%). The SGRQ and Medical Research Council dyspnoea score were used to measure quality of life in this study two years after discharge from hospital. This study showed that only frequency of COPD exacerbations and dyspnoea grade were strongly associated with all SGRQ scores thus reflecting HRQoL. 4 
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Hurel et al prospectively studied a general intensive care population, of whom 35 (16%) were patients with COPD. The Nottingham Health Profile (NHP) and Perceived Quality of life (PQOL) were used. These were posted out six months after discharge from the ICU. The whole population was 589, of whom 425 (71%) survived to discharge. Of the patients followed up, 62 died before six month follow-up and 34 patients were lost to follow-up. Only 223 (34% of admissions) returned correctly completed questionnaires. No details are available of how many of the returned questionnaires were from COPD patients who had been invasively ventilated, but multivariate analysis showed that treatment by mechanical ventilation had no influence on HRQoL as assessed by NHP (part I only) and PQOL. However the medical admissions, 24% of whom were COPD patients, had lower HRQoL. 10 Almagro et al prospectively studied a cohort of 141 COPD patients who were admitted to hospital; only eight were invasively ventilated. Of the patients included, 64 (45%) patients died in hospital and six patients were lost before the discharge HRQoL questionnaire could be administered. The SGRQ were administered on the day before hospital discharge, making results of the HRQoL less valid. No specific results on the invasively ventilated patients are available but worse SGRQ scores correlated with increased mortality. 8 Connors et al performed a prospective cohort study with a subset of patients from the SUPPORT study, 18 including all 
QoL assessment
patients admitted to hospital for exacerbation of COPD. Of the 1,016 patients included, 900 (89%) survived hospital admission. In this study, 543 patients spent at least one day in ICU while 358 (66% of admissions to ICU) required mechanical ventilation. At two months, the surviving patients completed the SIP. The results of 416 returned questionnaires showed a mean of 20 points, median 18, and interquartile range 9-28 (compared to ARDS patients who scored a mean of 40 at two weeks, 3, 6 and 12 months 19 ). The results showed that, of 517 patients who were asked about ADL (Activities of Daily Living), 46% were independent, 23% had one dependency (needed help with at least one ADL), 15% had 2-3 dependencies and 17% had more than three dependencies. Of the 518 patients asked how they would rate their present HRQoL, 6% said excellent, 15% very good, 30% good, 28% fair and 20% poor. Of the 487 patients asked to rate their health between 0 and 100, 15% rated between 81-100, 28% between 61-80, 31% between 41-60, 14% between 21-40 and 11% between 0 and 20. From a time trade-off question, 64% of patients would trade a year of their current health for a lesser time with good health. No data was published on specifically the invasively ventilated patients, but the study showed reduced survival was observed in patients who required mechanical ventilation (n=348, 57% 180-day survival) or ICU stay (n=526, 63% 180-day survival). 2 Ambrosino et al performed a prospective, cohort-controlled trial of patients with COPD who survived mechanical ventilation. Sixty-three patients with COPD who required ventilation were recruited and the control group was 34 patients with COPD on LTOT with no previous ICU admissions. The HRQoL measures used were NHP and Mini Mental State Evaluation (MMSE); these were administered at discharge, three and six months. Of the patients enrolled, 18 were non-invasively ventilated, 17% were lost to follow-up, 10% died before follow-up and 36 completed the study. In the control group, one died and 13 were lost to follow-up. Twenty of the control group completed the study. No distinction could be made between patients who were invasively ventilated and those that were non-invasively ventilated. After three and six months, there were no significant differences between groups in any dimension, and health status at three months was similar to stable COPD patients. MMSE results were similar; differences between groups were significant at discharge but not after three to six months. 12 Combes et al performed a prospective cohort study on patients who needed long-term mechanical ventilation for over 14 days. There were 347 patients included in the study; 150 died in the ICU (43%) and 40 were lost to follow-up, leaving 157 patients (45%). The HRQoL measurement was performed in February 2000. Fifty-eight patients had died after discharge before Feb 2000, 99 were alive, two did not reply, 10 had incomplete questionnaires; the final complete questionnaire count was 87. In this study, 8% of patients included were COPD patients. The NHP and SGRQ questionnaires were completed an average of three years after discharge from ICU. No specific data were published on the COPD patients who were invasively ventilated but having COPD was not an independent predictor of ICU mortality or worse HRQoL scores. 11
Discussion
The patient populations reviewed are quite different. Only one study examined all ICU admissions and identified a sub-group of COPD patients, 10 so guaranteeing identification of all eligible patients. Two of the trials enrolled long-term ventilated patients which may not include all patients with COPD. 9, 11 The diagnostic criteria for COPD were variable so the groups studied are not homogeneous. The nine studies identified used different measures of HRQoL with only three using the diseasespecific SGRQ, and these were applied at differing times. Only two of the studies included both a disease-specific and a generic HRQoL questionnaire. This may be ideal as the disease-specific questionnaire would evaluate the disease-specific HRQoL, while the generic questionnaire would evaluate the ICU component of the HRQoL. Depression plays a major role in the HRQoL of COPD patients, but only the Spanish HRQoL questionnaire asked about depression and anxiety. The review may be biased by the small numbers included in some of the studies.
Three studies sent out questionnaires at six months or less 8, 10, 12 and one did their follow-up at discharge. 14 Two studies did not have a fixed time after patient discharge for a HRQoL assessment. 9, 11 Two studies followed up their patients more than one year after discharge. 4, 13 One study did its HRQoL questionnaire six years after discharge, which is a long time taking into account continuing mortality after discharge and re-admission. 13 If 30-50% of patients who survive invasive ventilation have another exacerbation within six months of hospital discharge, and mortality rates at six months, one, three and five years after invasive ventilation are 39%, 43%, 61% and 76% respectively; 20 the ideal time for HRQoL assessment would have been at 2-3 months, six months and then at one year.
The heterogeneity of study design and outcome measures made it impossible to combine the results from different studies. Heyland reviewed 1,073 articles on the practice of ICU and found that only 1.7% included HRQoL measurements, and of those no comparisons could be made as the studies used too wide a variety of outcome measures. 21 Gill and Feinstein randomly selected 75 articles from three databases on HRQoL and found that 136 of 159 instruments used to measure HRQoL had been used only once. 22 Of the instruments used in the studies, the best studied and the most widely used generic HRQoL tool is the SF-36. The SGRQ has been used in ICU but not extensively. All studies seem to have a large number of patients lost to follow-up. Bias will have been introduced as only the patients who are well enough to fill in the questionnaire returned it so selecting the patients with better outcomes. The mortality differences in the different trials are striking and could be a reflection of the different patient population studied or that some of the patients lost to followup had died. This review suggests that HRQoL of COPD patients does deteriorate after invasive ventilation but that it returns to levels that are comparable to COPD patients who are on LTOT and patients enrolled in pulmonary rehabilitation. 16, 17 The HRQoL as measured by SIP shows COPD patients to be better off than ARDS patients. 19 Pulmonary rehabilitation does seem to improve HRQoL but none of these studies mentioned pulmonary rehabilitation. 23 The ideal study would be inclusive (ie a sample that is representative of the population), enrol all patients with COPD and include units that represent the UK population (ie teaching hospitals and district general hospitals). The study should be large enough to make the results meaningful. The diagnosis of COPD will be problematic, as it can be nearly impossible to distinguish between chronic severe asthma and COPD; all patients with airflow obstruction will need to be included. The control group should ideally be communitybased case-matched controls. The confounding factors for HRQoL, such as steroid use, theophylline use, and comorbidities should be matched between controls and the observed population. All the patients eligible for pulmonary rehabilitation should have received this intervention. The outcome measures should be SF-36 and SGRQ.
